Timothy Law, MD
Colon & Rectal Surgery · Roseville, CANPI 1144632266
Payments from drug & device makers
Across 28 payments — averaging $148.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Edwards Lifesciences$134
- Johnson & Johnson$114
- Pacira Pharmaceuticals Incorporated$110
- Stryker$106
- Takeda Pharmaceuticals U.S.A., Inc.$81
- plus $316 from 12 others
What the payments were for
- Travel & lodging$71017%
- Food & beverage$95023%
- Education$2,50060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 7 | $3,298 |
| Edwards Lifesciences | 1 | $134 |
| Johnson & Johnson | 1 | $114 |
| Pacira Pharmaceuticals Incorporated | 1 | $110 |
| Stryker | 1 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $81 |
| Incyte Corporation | 2 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $41 |
| AstraZeneca | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Novartis | 1 | $29 |
| Pfizer | 1 | $25 |
| Biocon Biologics Inc | 1 | $24 |
| Taiho Oncology, Inc. | 1 | $23 |
| Shire North American Group Inc | 1 | $19 |
| Sanofi | 1 | $18 |
| Integra Lifesciences Corporation | 1 | $16 |
| Kerecis Limited | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,160 in reported general payments places this provider in the 50th percentile of 176 colon & rectal surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 68 | $4,176 |
| Metronidazole | 36 | $175 |
| Oxycodone Hcl | 31 | $131 |
| Neomycin Sulfate | 29 | $68 |
| Tramadol Hcl | 25 | $46 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $4 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Roseville
- Shohrat AnnaberdyevRoseville$101K
- Sang LeeLos Angeles$2.6M
- Pamela LeeSan Diego$544K
- Phillip FleshnerWest Hollywood$404K
- Hueylan ChernSan Francisco$328K
- Joseph CarmichaelOrange$179K
- Samuel EisensteinSan Diego$147K
- Elizabeth RaskinSacramento$126K
- Alessio PigazziLos Angeles$100K
- Kyle CologneLos Angeles$98K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.